The first stop for professional medicines advice

Preparing Comirnaty 10 (XBB.1.5) ready to use vaccine

Published Last updated See all updates
Topics: COVID-19 vaccinePreparing

An example SOP for preparing Comirnaty 10 (XBB.1.5) ready to use vaccine.

This article forms part of a series
  1. Managing COVID-19 Vaccines: Guidance and SOPs
    1. Ordering, receiving and storing COVID-19 vaccines
    2. Transporting COVID-19 vaccines
    3. Safe and secure handling, spillage and disposal of COVID-19 vaccines
    4. Moving COVID-19 vaccines legally within the NHS
    5. Preparing Comirnaty 30 micrograms (XBB.1.5) vaccine
    6. Preparing Comirnaty 10 (XBB.1.5) ready to use vaccine
    7. Preparing Comirnaty 3 (THREE) (XBB.1.5) concentrate vaccine
    8. Preparing Spikevax (XBB.1.5) vaccine

Understanding our terminology

Comirnaty Omicron XBB.1.5 10 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) raxtozinameran must be prepared carefully following the manufacturer’s instructions. We refer to it as Comirnaty 10 (XBB.1.5) ready to use in our web articles.

Example procedure

We have produced an example template Standard Operating Procedure (SOP) for the preparation of the Comirnaty 10 (XBB.1.5) ready to use vaccine. The attachment is presented in Word to enable adaptation locally, or as reference source to check that existing local procedures are robust and comprehensive. Within the SOP, red text indicates where detail is to be added locally.

Attachments

Update history

  1. SOP updated to version 1.1. Updated to correct dust cap colour from grey to blue
  1. Published